Literature DB >> 9220596

The role of biotechnologically engineered vaccines and diagnostics in pseudorabies (Aujeszky's disease) eradication strategies.

W L Mengeling1, S L Brockmeier, K M Lager, A C Vorwald.   

Abstract

Modern-day biotechnology has an almost unlimited number of possibilities for reducing the impact of hereditary and infectious diseases. To date one of its most visible and rewarding applications for veterinary medicine has been in the genetic engineering of vaccines and diagnostics to assist in the eventual eradication of pseudorabies (PR, Aujeszky's disease). In the following review we summarize some of the most pertinent issues relative to PR eradication and point out the present and potential role of biotechnology in achieving our goal.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9220596     DOI: 10.1016/s0378-1135(96)01306-5

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  4 in total

1.  Seroprevalence of porcine reproductive and respiratory syndrome, Aujeszky's disease, and porcine parvovirus in replacement gilts in Thailand.

Authors:  Padet Tummaruk; Rachod Tantilertcharoen
Journal:  Trop Anim Health Prod       Date:  2011-11-09       Impact factor: 1.559

2.  The probability of in vivo reactivation of herpes simplex virus type 1 increases with the number of latently infected neurons in the ganglia.

Authors:  N M Sawtell
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

3.  Bartha-K61 vaccine protects nursery pigs against challenge with novel european and asian strains of suid herpesvirus 1.

Authors:  Konstantinos V Papageorgiou; Margarita Michailidou; Ioannis Grivas; Evanthia Petridou; Efthymia Stamelou; Konstantinos Efraimidis; Lei Chen; Trevor W Drew; Spyridon K Kritas
Journal:  Vet Res       Date:  2022-06-22       Impact factor: 3.829

Review 4.  Porcine Reproductive and Respiratory Syndrome Virus Reverse Genetics and the Major Applications.

Authors:  Jayeshbhai Chaudhari; Hiep L X Vu
Journal:  Viruses       Date:  2020-10-31       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.